Nishant K. Mishra, MD

Dr. Mishra is an Assistant Professor of Neurology in the Division of Stroke and Vascular Neurology at Yale University. He has a long-standing interest in stroke medicine. In 2005, he earned his medical degree from the Maharashtra University of Health Sciences, India. After a year of service in Neurology at a Mumbai Hospital, he received Swiss Federal Commission’s ESKAS Fellowship to train at the University Hospital of Lausanne (CHUV) from 2006 - 2008. At CHUV, he managed patients in stroke and behavioral neurology clinics and conducted clinical research about the behavioral manifestations of acute stroke (e.g., blind sight & neglect syndromes). He then went to the University of Glasgow, Scotland, and earned a PhD in Medicine and Therapeutics in 2012. For his PhD, he studied the use of i.v. alteplase in acute ischemic stroke patients who were recommended for exclusion as per the European Drug Authority, EMEA. Dr. Mishra’s doctoral work made significant contributions to the field, informing whether the exclusion criteria proposed by the drug authorities were meaningful and should be followed. From 2012 - 2014, he was at Stanford University for post-doctoral work in Vascular Neurology. At Stanford, he studied the brain imaging profiles of ischemic stroke patients, which are associated with improved outcomes after receiving reperfusion stroke therapy in extended time window. Subsequently, and after a year at the U.S. Food and Drug Administration (FDA), he began his U.S. clinical training. For his residency and fellowship trainings, he was at Tulane University, New Orleans (2016 - 2018), Icahn School of Medicine at Mount Sinai, New York (2018 - 2020), and University of California, Los Angeles (2020 - 2021). Dr. Mishra's professional goals are to make a positive impact in the lives of the stroke patients, not only locally by offering the best care to his patients, but also globally by advancing the field through clinical research and novel discoveries.